Biotech companies have to follow lots of tricky industry rules and laws. These include FDA rules, good manufacturing practices, recall insurance, and supplement labeling requirements. A 2023 SEMrush study says alternative proteins have huge business potential. By 2050, they could make up 4% of all protein produced. That would create…